Papers: 10.3390/jcm9061663
https://doi.org/10.3390/jcm9061663
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Cited by: 6
Author(s): Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, Markus J. Steiner, Claudia Monzo-Fuentes, Thomas Melchardt, Teresa Magnes, Florian Huemer, Theresa Westphal, Clemens Hufnagl, Cornelia Hauser‐Kronberger, Alexander Egle, Richard Greil
Published: about 5 years ago
Software Mentions 6
Very Likely Science (78)
cran: glmnet
Lasso and Elastic-Net Regularized Generalized Linear ModelsPapers that mentioned: 1,607
Very Likely Science (100)
Very Likely Science (75)
Very Likely Science (100)
Very Likely Science (100)
Very Likely Science (90)